Targeting nanoparticles rotate faster and move across larger areas
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target.
A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets — by simply analyzing each nanoparticle’s distinct movements in real time.
By studying drug-loaded gold nanostars on cancer cell membranes, the researchers found that nanostars designed to target cancer biomarkers transited over larger areas and rotated much faster than their non-targeting counterparts. Even when surrounded by non-specifically adhered proteins, the targeting nanostars maintained their distinct, signature movements, suggesting that their targeting ability remains uninhibited.
“Moving forward, this information can be used to compare how different nanoparticle characteristics — such as particle size, shape and surface chemistry — can improve the design of nanoparticles as targeting, drug-delivery agents,” said Northwestern’s Teri Odom, who led the study.
The medical field has long been searching for alternatives to current cancer treatments, such as chemotherapy and radiation, which harm healthy tissues in addition to diseased cells. Although these are effective ways to treat cancer, they carry risks of painful or even dangerous side effects. By delivering drugs directly into the diseased area — instead of blasting the whole body with treatment — targeted delivery systems result in fewer side effects than current treatment methods.
“The selective delivery of therapeutic agents to cancer tumors is a major goal in medicine to avoid side effects,” Odom said. “Gold nanoparticles have emerged as promising drug-delivery vehicles that can be synthesized with designer characteristics for targeting cancer cells.”
Various proteins, however, tend to bind to nanoparticles when they enter the body. Researchers have worried that these proteins might impede the particles’ targeting abilities. Odom and her team’s new imaging platform can now screen engineered nanoparticles to determine if their targeting function is retained in the presence of the adhered proteins.
The Latest on: Drug-delivery nanoparticles
via Google News
The Latest on: Drug-delivery nanoparticles
- Ocular Drug Delivery Technology Market by Growth 2019 - Technological Strategies, Business Advancements and Top-Vendor Landscape 2028on August 19, 2019 at 12:15 am
Global ocular drug delivery technology market segmentation, by formulation type: Solution Suspension Liposomes Emulsion Nanoparticles Nano suspensions Others (Niosomes, dendrimers) 1.Detailed overview ...
- Fluorescent carbon dots could make cancer treatment safer and more effectiveon August 16, 2019 at 6:46 am
These nanoparticles were made using common ingredients such ... Jose Ricardo Aguilar Cosme, a PhD Engineering Materials student, said: “The development of new drug delivery approaches can make drugs ...
- RNAI Technology Market: Industry Analysis Outlook By Size, Share, Growth, Trends And Forecast 2016-2022on August 16, 2019 at 2:52 am
The further bifurcations for the segments is represented below: On the basis of Type of Application o Drug Discovery and Development o Therapeutics o Drug Delivery > Nanoparticle Drug Delivery ...
- Ocular Drug Delivery Technology Market 2019-2028 | Competitive Landscape and Industrial Growthon August 15, 2019 at 6:33 am
cyclodextrines), Global ocular drug delivery technology market segmentation, by formulation type: Solution, Suspension, Liposomes, Emulsion, Nanoparticles, Nano suspensions, Others (Niosomes, ...
- Nanoscale 'glass' bottles could enable targeted drug deliveryon August 15, 2019 at 5:22 am
Tiny silica bottles filled with medicine and a special temperature-sensitive material could be used for drug delivery to kill ... polystyrene with a small gold nanoparticle embedded in its surface.
- Global Central Nervous System Diseases Drug Delivery Research Report 2019 - ResearchAndMarkets.comon August 12, 2019 at 4:43 am
The "Drug Delivery in Central Nervous System Diseases - Technologies ... Various routes of administration as well as conjugations of drugs, e.g., with liposomes and nanoparticles, are considered. Some ...
- Nanoparticles' movements reveal whether they can hit intended cancer targetson August 10, 2019 at 8:57 pm
A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets -- by simply analyzing each ...
- Way developed to determine effectiveness of drug-delivery nanoparticles: studyon August 10, 2019 at 1:32 pm
CHICAGO, Aug. 10 (Xinhua) -- Researchers at Northwestern University (NU) have developed a way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended ...
- Nanoparticles' movements reveal whether they can successfully target canceron August 9, 2019 at 1:26 pm
A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets—by simply analyzing ...
- Brain-targeted drug delivery by manipulating protein corona functionson August 8, 2019 at 2:30 am
SP-sLip preserve functions of the absorbed human plasma ApoE, and the corona-mediated targeting strategy works in SP modified PLGA nanoparticles. The present study may pave a new avenue to facilitate ...
via Bing News